Vendor Intelligence Report: Kandies

Published 3 Jul 2026. 17-page investigative report on who is behind Kandies: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Kandies is a private-channel peptide seller with one real but narrow product signal. Across 4 Finnrick lab tests the overall pass rate is 75% (3 pass / 1 fail). The record is entirely Retatrutide, which makes Kandies more credible than an untested Discord source for that peptide, but does not support a vendor-wide safety read or extrapolation to any other compound.

The identity work is the central caution. The report did not document a verified legal entity, named owner, disclosed provider, public catalog, canonical storefront, or public COA-authentication system. The obvious domain trail does not validate the peptide channel: kandies.com carries an unrelated candy-business closure notice, Certificate Transparency showed no public SSL certificates, and a second Kandies-looking domain leads to another candy-store dead end.

For Retatrutide, Kandies reads as plausible only if a buyer can get lot-matched, independently verifiable batch evidence. The score rests on a small sample, includes a failure, and is sensitive to stricter grading views. PeptideBenchmark adds a public profile, but that signal is Finnrick-derived and lacks cross-coverage from major review sources; the public X/web scan also found no coupon or affiliate network, with private-platform gaps left open.

Inside the full report:

  • Retatrutide lab record, rating trajectory, and methodology-divergence charts.
  • Domain provenance exhibits for kandies.com and lakandies.com, including RDAP and Certificate Transparency findings.
  • Identity checks on Kimjigy, the WhatsApp number, X/TikTok/Reddit dead ends, and the Discord invite open lead.
  • PeptideBenchmark profile analysis and missing Peptide Critic, Trustpilot, and Pep Review Pro coverage.
  • Buyer-risk matrix for supplier opacity, batch consistency, brand-channel confusion, and regulatory continuity.

Risk assessment

  • Supplier/manufacturer opacity and operator-transparency risk — high: Kandies is documented through Gmail/WhatsApp/Discord and a directory note that the group will not disclose its provider; no legal entity, owner, address, or supplier was verified.
  • Retatrutide batch-consistency risk — medium: Retatrutide is the only Finnrick-tested product for Kandies: 4 tests (3 pass / 1 fail), current rating 78.96%; other products have no product-specific Finnrick record.
  • Brand-verification and channel-confusion risk — medium: kandies.com and lakandies.com were unrelated candy-domain leads, and no public official-channel list, authorized-reseller list, or anti-counterfeit process was documented.
  • Regulatory-continuity risk — medium: No Kandies-specific enforcement was found, but 2026 FDA actions against similar peptide sellers and proposed federal restrictions make private-channel continuity fragile.